Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials

समान संसाधन

• Serum and Cerebrospinal Fluid Pharmacokinetics of Intravenous and Oral Lamivudine in Human Immunodeficiency Virus-Infected Children
  द्वारा: Mueller, Brigitta U., और अन्य
  प्रकाशित: (1998)
• Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.
  द्वारा: Heald, A E, और अन्य
  प्रकाशित: (1996)
• A Population Pharmacokinetic Analysis of Nelfinavir Mesylate in Human Immunodeficiency Virus-Infected Patients Enrolled in a Phase III Clinical Trial
  द्वारा: Jackson, Kimberley A., और अन्य
  प्रकाशित: (2000)
• Predictive Value of Pharmacokinetics-Adjusted Phenotypic Susceptibility on Response to Ritonavir-Enhanced Protease Inhibitors (PIs) in Human Immunodeficiency Virus-Infected Subjects Failing Prior PI Therapy
  द्वारा: Eron, Joseph J., और अन्य
  प्रकाशित: (2009)
• Steady-State Pharmacokinetics of Lamivudine in Human Immunodeficiency Virus-Infected Patients with End-Stage Renal Disease Receiving Chronic Dialysis
  द्वारा: Bohjanen, Paul R., और अन्य
  प्रकाशित: (2002)